Picture of OptiNose logo

OPTN — OptiNose News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

OptiNose Inc expected to post a loss of 72 cents a share - Earnings Preview

OptiNose Inc OPTN.OQ OPTN.O is expected to show a rise in quarterly revenue when it reports  results on March 20 for the period ending December 31 2024

The Yardley Pennsylvania-based  company is expected to report a 12.3% increase in revenue to $22.307 million from $19.87 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on November 12 2024, for the period ended December 31, was for revenue between $19.00 million and $23.00 million.

​LSEG's mean analyst estimate for OptiNose Inc is for a loss of 72 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for OptiNose Inc is $17.50​, above​ its last closing price of $5.88. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Sep. 30 2024-0.79-0.790.00Beat100
Jun. 30 2024-1.11-1.16-0.75Beat35.3
Mar. 31 2024-1.63-1.61-1.80Missed-11.6​
Dec. 31 2023-1.42-1.41-1.35Beat4.6
​​Sep. 30 2023-1.42-1.41-1.20Beat15.2
Jun. 30 2023-1.61-1.630.30Beat118.4​
Mar. 31 2023-2.06-2.09-2.55Missed-22
Dec. 31 2022-2.60-2.62-2.55Beat2.7
This summary was machine generated March 18 at 12:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on OptiNose

See all news